Alchemia names Thomas Liquard CEO
This article was originally published in Scrip
Executive Summary
Alchemia, a drug discovery and development company, has appointed Thomas Liquard CEO following the departure of Charles Walker. Mr Liquard, who joined Alchemia in December 2013 as chief operating officer, most recently served as senior director, portfolio development lead emerging markets for the Established Products portfolio at Pfizer, where he served for seven years in various roles.